Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Madrigal Pharmaceuticals, Inc. (MDGL) had Revenue of $137.25M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$137.25M
Net Income	$-73.24M
Cost of Goods Sold	$4.51M
Gross Profit	$132.74M
Operating Expenses	$216.56M
Operating Income	$-79.31M
Non-Operating Income/Expense	$6.07M
Pre-Tax Income	$-73.24M
Normalized Pre-Tax Income	$-73.24M
Income after Taxes	$-73.24M
Income from Continuous Operations	$-73.24M
Consolidated Net Income/Loss	$-73.24M
Normalized Income after Taxes	$-73.24M
EBIT	$-79.31M
EBITDA	$-78.44M
Weighted-Average Shares Outstanding (Basic)	22.09M
Weighted-Average Shares Outstanding (Diluted)	22.09M
Earnings per Share (EPS) (Basic)	$-3.32
Earnings per Share (EPS) (Diluted)	$-3.32
Balance Sheet Financials
Current Assets	$987.98M
Property, Plant, and Equipment	$1.90M
Long-Term Assets	$8.65M
Total Assets	$996.63M
Current Liabilities	$167.24M
Long-Term Debt	$118.00M
Long-Term Liabilities	$118.75M
Total Liabilities	$285.99M
Common Equity	$710.64M
Tangible Shareholders Equity	$706.00M
Shareholders Equity	$710.64M
Common Shares Outstanding	22.19M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-88.89M
Cash Flow from Investing Activities	$163.88M
Cash Flow from Financial Activities	$8.64M
Beginning Cash	$105.02M
End Cash	$188.65M
Increase/Decrease in Cash	$83.63M
Stock-Based Compensation	$20.93M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.91
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.14
Debt to Equity Ratio	0.17
Gross Margin	96.71%
Operating Margin	-57.79%
EBIT Margin	-57.79%
EBITDA Margin	--
Pre-Tax Profit Margin	-53.36%
Profit Margin	-53.36%
Free Cash Flow	$-88.89M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.14
Inventory Turnover	0.08
Receiveable Turnover	2.23
Days Sales in Receivables	40.28
Return on Equity	-10.31%
Return on Tangible Equity	-10.37%
Return on Assets	-7.35%
Return on Investments	-8.84%
Book Value Per Share	$32.03
Free Cash Flow per Share	$-4.02
Operating Cash Flow per Share	$-4.02

Data from Zacks Investment Research, Inc.